Small Caps has featured the results from Orthocell’s recent study that shows an 82% success rate using its novel stem cell therapy treatment for chronic tendon injuries.
Read the article HERE.
Small Caps has featured the results from Orthocell’s recent study that shows an 82% success rate using its novel stem cell therapy treatment for chronic tendon injuries.
Read the article HERE.